FUBP1 and cancer: In patients with CESC, CHOL, ESCA, GBM, LUAD, MESO, SARC, and STAD, either low-level methylation or no methylation of FUBP1 was observed, indicating the high expression of FUBP1 in the abovementioned cancer types (Figure 4).